FEATURE: WATER TREATMENTh h f “We have admittedly been fortunate with much of our timing for market entry, some by design and some by luck. Several requirements have changed, even over just the last year. Being currently in the middle of our Type Approval testing however, we are able to incorporate the new G8 testing requirements, as well as all current guidance from The US Coast Guard and the EPA.” – Matt Hughes P.E., Envirocleanse Executive VP of Marketing & Salespathogens, the Concentration-Time (CT) treatment stallation (compared to inline treatment systems), making approach is utilized. The recirculation capacity enables re